Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED) News and Updates

1 - 3 of 3

Breakthrough New Therapies Approved for the Treatment of Sickle Cell Disease

The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.

Read more

New Studies Provide Important New Clues For Treating Red Blood Cell Disorders

Published on in CHOP News

Stefano Rivella, PhD, an expert in creating the next-generation lentiviral vectors for the cure of hemoglobinopathies including sickle cell disease (SCD), as well as a leader in the discovery of erythroid and iron disorders including beta-thalassemia, has led three new published studies that make significant contributions to the scientific body of literature regarding red blood cells, and how manipulating the production of red cells can lead to the development of new disease-modifying therapies.